Asia's Leading Expert in Early Lung Cancer Imaging Diagnosis
The earlier lung cancer is detected, the better the outcome. Stage I lung cancer has a five-year survival rate exceeding 80% — compared to less than 10% for stage IV disease. The key to early detection is expert imaging interpretation: knowing which nodules on a CT scan are truly suspicious, which can be safely monitored, and which require immediate action. At Changzheng Hospital in Shanghai, Prof. Liu Shiyuan has built a career at the absolute frontier of lung cancer imaging — with a diagnostic accuracy rate of 94.7% and a leadership role that spans the entire Asia-Pacific region.
Featured Specialist: Prof. Liu Shiyuan (刘士远)
Prof. Liu Shiyuan is Director of the Department of Radiology at Changzheng Hospital, Naval Medical University (Haijun Junyi Daxue Changzheng Yiyuan) — one of Shanghai's major military-affiliated academic medical centers. His international standing is exceptional:
- President of the Asian Society of Thoracic Radiology (ASTR) — the premier professional organization for thoracic imaging specialists across Asia, representing radiologists from Japan, Korea, China, India, Southeast Asia, and beyond
- 94.7% diagnostic accuracy for early lung cancer — a benchmark that reflects both technical expertise and deep clinical experience with the full spectrum of pulmonary nodule presentations
- Lead author and principal contributor to multiple national lung nodule screening guidelines in China — the standards followed by radiologists and pulmonologists across the country
- Internationally recognized authority on low-dose CT lung cancer screening, nodule characterization, and AI-assisted imaging diagnosis
Why Expert Imaging Interpretation Changes Everything
A CT scan of the chest is only as valuable as the expertise of the person interpreting it. The same nodule can be read very differently by different radiologists — with significant consequences for the patient:
- Under-reading: A malignant nodule dismissed as benign, leading to delayed diagnosis and upstaging
- Over-reading: A benign nodule flagged as suspicious, leading to unnecessary biopsy, surgery, or patient anxiety
- Incorrect characterization: Misidentifying nodule density (solid vs. ground-glass vs. part-solid) leads to inappropriate management recommendations
- Missed findings: Small or subtle nodules overlooked on a busy scan
Prof. Liu's 94.7% diagnostic accuracy — validated across a large clinical series — means that patients who bring their CT scans to him receive the most reliable possible interpretation of what those images show.
Lung Nodule Characterization: What Prof. Liu Evaluates
Prof. Liu's imaging assessment goes far beyond simply noting the presence of a nodule. His comprehensive evaluation includes:
- Size and volume: Precise measurement using 3D volumetric software
- Density classification: Solid, pure ground-glass opacity (pGGO), or part-solid (mixed GGO)
- Morphological features: Spiculation, lobulation, pleural tethering, air bronchograms, vascular convergence
- Growth rate assessment: Volume doubling time calculation from serial CT scans
- Location and relationship to structures: Proximity to vessels, bronchi, pleura, and fissures
- Associated findings: Mediastinal lymphadenopathy, pleural effusion, satellite nodules
- AI-assisted analysis: Integration of computer-aided detection and deep learning tools to supplement expert visual assessment
National Screening Guidelines: Setting the Standard
As the lead author of multiple national lung nodule screening guidelines, Prof. Liu has directly shaped how lung cancer screening is practiced across China. These guidelines determine:
- Which populations should undergo low-dose CT screening (age, smoking history, occupational exposure, family history)
- How nodules of different sizes and densities should be managed (surveillance interval, biopsy threshold, surgical referral criteria)
- How to report and communicate nodule findings to referring clinicians
- Quality standards for CT acquisition and interpretation in screening programs
For international patients, this means that a second-opinion imaging review by Prof. Liu is not just an expert opinion — it is a review by the person who wrote the national standards against which all other radiologists are measured.
Second-Opinion Imaging Review for International Patients
One of the most valuable services Prof. Liu offers international patients is a formal second-opinion review of CT scans performed elsewhere. This is particularly valuable for:
- Patients told they have a suspicious nodule who want confirmation before proceeding to biopsy or surgery
- Patients told their nodule is benign who want reassurance from Asia's leading expert
- Patients with multiple nodules requiring comprehensive characterization and management planning
- Patients whose nodule has been growing on serial scans and need expert assessment of the significance
- Patients with ground-glass opacity nodules — a particularly nuanced area where expert interpretation is critical
How CMCS Coordinates Your Imaging Review
China Medical Concierge Shanghai (CMCS) is a health management company — not a hospital. We connect international patients with Shanghai's leading imaging specialists, including Prof. Liu Shiyuan at Changzheng Hospital, and manage every step of the process:
- Secure transfer of your CT imaging files (DICOM format) to Prof. Liu's team for review
- Scheduling of in-person consultation or remote imaging review as appropriate
- Translation of the imaging report into English for international patients
- Coordination with thoracic surgery, pulmonology, or interventional radiology based on Prof. Liu's findings
- Medical interpretation during consultations
- Logistics support for patients traveling to Shanghai for in-person evaluation
Get in Touch
If you have a pulmonary nodule or lung mass and want the most expert possible imaging interpretation in Asia, contact our team for a confidential consultation.
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
0件のコメント